Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna R K, Franklin"'
Publikováno v:
Blood Advances. 7:2042-2046
Advances in treatment have reduced mortality from Hodgkin lymphoma; therefore, greater attention should be focused on minimizing the late effects. A variety of risk-adapted treatment regimens exist that prioritize disease presentation but not patient
Autor:
Lindsey A. Murphy, Kristen Miller, Amanda C. Winters, Anna R. K. Franklin, Michael R. Verneris, Amy K. Keating
Publikováno v:
Bone Marrow Transplantation. 58:343-345
Autor:
Christopher Jon Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia N. Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca Deyell, Jamie E Flerlage, Anna R. K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E Norris, Martha Pacheco, Faye K Willen, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino-Roth
Publikováno v:
Blood Advances.
Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with approximately 50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-fr
Publikováno v:
Blood advances.
Advances in treatment have reduced mortality from Hodgkin Lymphoma (HL) and made it so greater attention can be focused on minimizing late effects. A variety of risk-adapted treatment regimens exist that prioritize disease presentation, but not patie
Autor:
Lindsey A, Murphy, Kristen, Miller, Amanda C, Winters, Anna R K, Franklin, Michael R, Verneris, Amy K, Keating
Publikováno v:
Bone marrow transplantation.
Publikováno v:
Blood. 140:3724-3725